Rushikesh Sable (Udo Rudloff)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 9

Top Topics

Transforming Growth Factor

Top Venues

Science translational medicine

Molecular cancer therapeutics

Molecular cancer research : MCR

This page only lists publications with an associated author ORCID identifier.

Publications

Sitanshu S Singh, Raul Calvo, Anju Kumari, Rushikesh V Sable, Yuhong Fang, Dingyin Tao, Xin Hu, Sarah Gray Castle, Saifun Nahar, Dandan Li, Emily Major, Tino W Sanchez, Rintaro Kato, Xin Xu, Jian Zhou, Liang Liu, Christopher A LeClair, Anton Simeonov, Bolormaa Baljinnyam, Mark J Henderson, Juan Jose Marugan, Rushikesh Sable
Fatty acid derivatization and cyclization of the immunomodulatory peptide RP-182 targeting CD206high macrophages improves anti-tumor activity. Molecular cancer therapeutics (2024)
Dandan Li, Anne M Miermont, Rushikesh V Sable, Humair S Quadri, Lesley Mathews Griner, Scott E Martin, Taivan Odzorig, Soumita De, Marc Ferrer, Astin S Powers, Stephen M Hewitt, Rushikesh Sable
Scaffolding protein connector enhancer of kinase suppressor of Ras 1 (CNKSR1) regulates MAPK inhibition responsiveness in pancreas cancer via crosstalk with AKT signaling. Molecular cancer research : MCR (2023)
Dandan Li, Nicholas Schaub, Theresa M Guerin, Tashinga E Bapiro, Frances M Richards, Vicky Chen, Keyur Talsania, Parimal Kumar, Debra J Gilbert, Jerome J Schlomer, Seong-Jin Kim, Rebecca Sorber, Yaroslav Teper, Wendy Bautista, Claudia Palena, Chan-Young Ock, Duncan Ian Jodrell, Nathan M Pate, Monika Mehta, Yongmei Zhao, Serguei Kozlov, Rushikesh Sable
T Cell-Mediated Antitumor Immunity Cooperatively Induced By TGFβR1 Antagonism and Gemcitabine Counteracts Reformation of the Stromal Barrier in Pancreatic Cancer. Molecular cancer therapeutics 20 (10) (2021)
Jesse M Jaynes, Rushikesh Sable, Michael H Ronzetti, Wendy Bautista, Zachary Knotts, Abisola Abisoye-Ogunniyan, Dandan Li, Raul Calvo, Myagmarjav Dashnyam, Anju Singh, Theresa Guerin, Jason White, Sarangan Ravichandran, Parimal Kumar, Keyur Talsania, Vicky Chen, Anghesom Ghebremedhin, Balasubramanyanam Karanam, Ahmad Bin Salam, Ruksana Amin, Taivan Odzorig, Taylor J Aiken, Victoria Nguyen, Yansong Bian, Jelani C Zarif, Amber E de Groot, Monika Mehta, Lixin Fan, Xin Hu, Anton Simeonov, Nathan M Pate, Mones S Abu-Asab, Marc Ferrer, Noel T Southall, Chan-Young Ock, Yongmei Zhao, Henry Lopez, Serguei Kozlov, Natalia De Val, Clayton C Yates, Bolormaa Baljinnyam, Juan Jose Marugan
Mannose receptor (CD206) activation in tumor-associated macrophages enhances adaptive and innate antitumor immune responses. Science translational medicine 12 (530) (2021)
Cara Kenney, Tricia Kunst, Santhana Webb, Devisser Christina, Christy Arrowood, Seth M Steinberg, Niharika B Mettu, Edward J Kim, Rushikesh Sable
Phase II study of selumetinib, an orally active inhibitor of MEK1 and MEK2 kinases, in KRASG12R-mutant pancreatic ductal adenocarcinoma. Investigational new drugs 39 (3) (2021)
Elias C Padilha, Pranav Shah, Amy Q Wang, Marc D Singleton, Emma A Hughes, Dandan Li, Kelly A Rice, Kylie M Konrath, Samarjit Patnaik, Juan Marugan, Rushikesh Sable, Xin Xu
Metabolism and pharmacokinetics characterization of metarrestin in multiple species. Cancer chemotherapy and pharmacology 85 (4) (2020)
Kevin J Frankowski, Chen Wang, Samarjit Patnaik, Frank J Schoenen, Noel T Southall, Dandan Li, Yaroslav Teper, Wei Sun, Irawati Kandela, Deqing Hu, Christopher Dextras, Zachary Knotts, Yansong Bian, John Norton, Steve Titus, Marzena A Lewandowska, Yiping Wen, Katherine I Farley, Lesley Mathews Griner, Jamey Sultan, Zhaojing Meng, Ming Zhou, Tomas Vilimas, Astin S Powers, Serguei Kozlov, Kunio Nagashima, Humair S Quadri, Min Fang, Charles Long, Ojus Khanolkar, Warren Chen, Jinsol Kang, Helen Huang, Eric Chow, Esthermanya Goldberg, Coral Feldman, Romi Xi, Hye Rim Kim, Gary Sahagian, Susan J Baserga, Andrew Mazar, Marc Ferrer, Wei Zheng, Ali Shilatifard, Jeffrey Aube, Rushikesh Sable, Juan Jose Marugan, Sui Huang
Metarrestin, a perinucleolar compartment inhibitor, effectively suppresses metastasis. Science translational medicine 10 (441) (2019)
G Aaron Hobbs, Nicole M Baker, Anne M Miermont, Ryan D Thurman, Mariaelena Pierobon, Timothy H Tran, Andrew O Anderson, Andrew M Waters, J Nathaniel Diehl, Bjoern Papke, Richard G Hodge, Jennifer E Klomp, Craig M Goodwin, Jonathan M DeLiberty, Junning Wang, Raymond W S Ng, Prson Gautam, Kirsten L Bryant, Dominic Esposito, Sharon L Campbell, Emanuel F Petricoin, Dhirendra K Simanshu, Andrew J Aguirre, Brian M Wolpin, Krister Wennerberg, Rushikesh Sable, Adrienne D Cox, Channing J Der
Atypical KRASG12R Mutant Is Impaired in PI3K Signaling and Macropinocytosis in Pancreatic Cancer. Cancer discovery 10 (1) (2019)
Dandan Li, John E Mullinax, Taylor Aiken, Hongwu Xin, Gordon Wiegand, Andrew Anderson, Snorri Thorgeirsson, Itzhak Avital, Rushikesh Sable
Loss of PDPK1 abrogates resistance to gemcitabine in label-retaining pancreatic cancer cells. BMC cancer 18 (1) (2018)